The use of complementary and alternative medicine (CAM) therapies by Turkish women with gynecological cancer

Purpose: To evaluate the prevalence and patterns of complementary and alternative medicine (CAM) utilization among Turkish women with gynecological cancer

Methods: In this cross-sectional study, a total of 156 patients treated between December 2002 and March 2005 at the Ministry of Health Aegean Obstetrics and Gynecology Teaching Hospital, Department of Gynecologic Oncology were evaluated. Data regarding CAM use were obtained from patients by means of face-to-face interviews.

Results: Sixty women (38.5%) had used CAM having been diagnosed with cancer; herbal medicine was the most common. The age, income, educational level, cancer site, FIGO stage, previous CAM usage, and time since patients were diagnosed with cancer were associated with CAM usage. The most (40%) commonly cited reason for CAM use was to boost the immune system. Although only 8.3% of CAM users received CAM information from health care professionals or CAM practitioners, this group of patients was more likely to discuss their CAM use with physicians.

Conclusion: Our data suggest that physicians should increase their knowledge of CAM therapies and ask cancer patients about previous CAM history.

Complementary and alternative medicine; Gynecologic cancers; Turkish women

[1] Lee M.M., Lin S.S., Wrensch M.R., Adler S.R., Eisenberg D "Alternative therapies used by women with breast cancer in four ethnic populations". J. Natl. Cancer Inst., 2000, 92, 42.

[2] Cui Y., Shu X.O., Gao Y., Wen W., Ruan Z.X., Jin F. et al.: "Use of complementary and alternative medicine by Chinese women with breast cancer". Breast Cancer Res. Treat., 2004, 85, 263.

[3] Cassileth B.R., Schraub S., Robinson E., Vickers A.: "Alternative medicine use worldwide: the International Union Against Cancer Survey". Cancer, 2001, 91, 1390.

[4] Salrnenpera L.: "The use of complementary therapies among breast and prostate cancer patients in Finland". Eur. J Cancer Care, 2002, 11, 44.

[5] Barnes P.M., Powell-Griner E., McFann K., Nahin R.L.: "Complementary and alternative medicine use among adults: United States, 2002". Adv. Data, 2004, 343, 1.

[6] Risberg T., Lund E., Wist E.: "Use of non-proven therapies. Differences in attitudes between Norwegian patients with non-malignant disease and patients suffering from cancer". Acta Oneal., 1995, 7, 893.

[7] Chrystal K., Allan S., Forgeson G., Isaacs R.: "The use of complementary/alternative medicine by cancer patients in a New Zealand regional cancer treatment center". N. Z. Med. J., 2003, 116, 1.

[8] Eisenberg D.M., Davis R.B., Ettner S.L., Appel S., Wilkey S., Van Rompay M. et al.: "Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey" JAMA, 1998, 280, 1569.

[9] Richardson M.A., Sanders T., Palmer J.L., Greisinger A., Singletary S.E.: "Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology". J. Clin. Oneal., 2000, 18, 2505.

[10] Sparber A., Bauer L., Curt G., Eisenberg D., Levin T., Parks S. et al.: "Use of complementary medicine by adult patients participating in cancer clinical trials". Oneal. Nurs. Forum, 2000, 27, 623.

[11] Complementary and Alternative Medicine. ACOG Committee Opinion Number 227. November, 1999.

[12] National Center for Complementary and Alternative Med,cme (http://nccam hlh gov/nccam/what-lS-cam/class1fy.shtml).

[13] American Cancer Society (http://www. cancer. org/al therapy/overwew.htm).

[14] Piao B.K., WangY.X., Xie G.R., Mansmann U., Matthes H., Beuth J. et al.: "Impact of complementary mistletoe extract treatment on quality of life in breast, ovarian and non-small cell lung cancer patients. A prospective randomized controlled trial". Anticancer Res., 2004, 24, 303.

[15] Schumacher K., Schneider B., Reich G., Stiefel T., Stoll G., Bock P.R. et al.: "Influence of postoperative complementary treatment with lectin-standardized mistletoe extract on breast cancer patients. A controlled epidemiological multicentric retrolective cohort study". Anticancer Res., 2003, 23, 3081.

[16] Cook C.A., Guerrerio J.F., Slater V.E.: "Healing touch and quality of life in women receiving radiation treatment for cancer: a rando mized controlled trial". A/tern. Ther. Health. Med., 2004, 10, 34.

[17] Jemal A., Muray T., Ward E., Samuels A., Tiwari R.C., Ghafoor A. et al.: "Cancer statistics, 2005". CA Cancer J. Clin., 2005, 55, 10.

[18] Swisher E.M., Cohn D.E., Goff B.A., Parham J., Herzog T.J., Rader J.S. et al.: "Use of complementary and alternative medicine among women with gynecologic cancers". Gynecol. Oncol., 2002, 84, 363.

[19] Von Gruenigen V.E., White L.J., Kirven M.S., Showalter A.L., Hopkins M.P., Jenison E.L.: "A comparison of complementary and alternative medicine use by gynecology and gynecologic oncology patients". Int. J. Gynecol. Cancer, 2001, 11, 205.

[20] Granai C.: "Expectations about alternative therapies and women with gynecological cancer". Curr. Opin. Obstet. Gynecol., 1999, 11, 3.

[21] Von Gruenigen V.E., Hopkins M.P.: "Alternative medicine in gynecologic oncology: a case report". Gynecol. Oncol., 2000, 77, 190.

[22] Richardson M.A.: "Complementary and alternative therapy use in gynecologic oncology: implications for clinical practice". Gynecol. Oncol., 2002, 84, 360.

[23] Sehouli J.: "How frequently do female patients with gynecological cancers use unconventional cancer therapies?". Gynecol. Oncol., 2000, 79, 336.

[24] Wenner C.A., Parker K., Simon M.A., Adams L., Greene K., Standish L.J.: "Botanical medicines with gynecological anticancer activity: a literature review". J. Am. Med. Womens Assoc., 1999, 54, 184.

[25] Downer S.M., Cody M.M., McCluskey P., Wilson P.D., Amott S.J., Lister T.A. et al.: "Pursuit and practice of complementary therapies by cancer patients receiving conventional treatment". Br. Med. J., 1994, 309, 86.

[26] Ernst E., Cassileth B.R.: "The prevalence of complementary/alternative medicine in cancer: a systematic review". Cancer, 1998, 83, 777.

[27] Katenkamp D., Hoyer H., Nagel G.: "Use of complementary and alternative medicine by patients with breast cancer: observations from a health-care survey". Support Care Cancer, 2004, 12, 789.

[28] Gozum S., Tezel A., Koc M.: "Complementary alternative treatments used by patients with cancer in eastern Turkey". Cancer Nurs., 2003, 26, 230.

[29] Ceylan S., Hamzaoglu 0., Komurcu S., Beyan C., Yalcin A.: "Survey of the use of complementary and alternative medicine among Turkish cancer patients". Complement Ther. Med., 2002, 10, 94.

[30] Algier L.A., Hanoglu Z., Ozden G., Kara F.: "The use of complementary and alternative (non-conventional) medicine in cancer patients in Turkey". Eur. J. Oncol. Nurs., 2005 (Epub ahead of print).

[31] Konrad L., Muller H.H., Lenz C., Laubinger H., Aumuller G., Lichius J.J.: "Antiproliferative effect on human prostate cancer cells by a stinging nettle root (Urtica dioica) extract". Planta Med., 2000, 66, 44.

[32] Akbay P., Basaran A.A., Undeger U., Basaran N.: "In vitro immunomodulatory activity of flavonoid glycosides from Urtica dioica L.". Phytother. Res., 2003, 17, 34.

[33] Ashikaga T., Bosompra K., O'Brien P., Nelson L.: "Use of complementary and alternative medicine by breast cancer patients: prevalence, patterns, and communication with physicians". Support Cancer Care, 2002, 10, 542.

[34] Jordan M.L., Delunas L.R.: "Quality of life and patterns of nontraditional therapy use by patients with cancer". Oneal. Nursing Forum, 2001, 28, 1107.

[35] Paltiel 0., Avitzour M., Peretz T., Cherny N., Kaduri L., Pfeffer R.M. et al.: "Determinants of the use of complementary therapies by patients with cancer". J. Clin. Oneal., 2001, 19, 2439.

[36] Shen J., Andersen R., Albert P.S., Wenger N., Glaspy J., Cole M. et al.: "Use of complementary/alternative therapies by women with advanced-stage breast cancer". BMC Complement. Altern. Med., 2002, 2, 8.

[37] Morris K.T., Johnson N., Homer L., Walts D.: "A comparison of complementary therapy use between breast cancer patients and patients with other primary tumor sites". Am. J. Surg., 2000, 179, 407.

[38] Burstein H.J., Gelber S., Guadagnoli E., Weeks J.C.: "Use of alternative medicine by women with early-stage breast cancer". N. J. Med., 1999, 340, 1733.

[39] Ernst E., Cassileth B.R.: "How useful are unconventional cancer treatments?". Eur. J. Cance, 1999, 35, 1608.

[40] Ang-Lee M.K., Moss J., Yuan C.S.: "Herbal medicine and perioperative care". JAMA, 2001, 286, 208.

[41] Heck A.M., DeWitt B.A., Lukes A.L.: "Potential interactions between alternative therapies and warfarin". Am. J. Health Syst. Pharm., 2000, 57, 1221.

[42] Spaulding-Albright N.: "A review of some herbal and related products commonly used in cancer patients". J. Am. Diet. Assoc., 1997, 97, 208.

[43] Boullata J., Nace A.: "Safety issues with herbal medicine". Pharmacotherapy, 2000, 20, 257.

[44] Palmer M.E., Haller C., McKinney P.E., Klein-Schwartz W., Tschirgi A., Smolinske S.C. et al.: "Advers events associated with dietary supplements: an observational study". Lancet, 2003, 361, 101.

[45] Izzo A.A., Ernst E.: "Interactions between herbal medicines and prescribed drugs: a systematic review". Drugs, 2001, 61, 2163.

[46] McCall M.R., F rei B.: "C an antioxidant vitamins materially reduce oxidative damage in humans?". Free Radicals Biol. Med., 1999, 26, 1034.

[47] Conklin K.A.: "Dietary antioxidants during cancer chemotherapy: impact on chemotherapeutic effectiveness and development of side effects". Nutr. Cance, 2003, 37, 1.

[48] Gulcin I., Kufrevioglu O.I., Oktay M., Buyukokuroglu M.E.: "Antioxidant, antimicrobial, antiulcer and analgesic activities of nettle (Urtica dioica L.)". J. Ethnopharmacol., 2004, 90, 205.

[49] Tahri A., Yamani S., Legssyer A., Aziz M., Mekhfi H., Bnouham M. et al.: "Acute diuretic, natriuretic and hypotensive effects of a continuous perfusion of aqueous extract of Urtica dioica in the rat". J. Ethnopharmacol., 2000, 73, 95.